Response to expression of concern regarding VIGOR study.
Reicin
Alise
A
Shapiro
Deborah
D
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003627:Data Interpretation, Statistical; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007783:Lactones / Q000009:adverse effects* / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000453:epidemiology; D009288:Naproxen / Q000009:adverse effects* / Q000627:therapeutic use; D012306:Risk; D013450:Sulfones / Q000009:adverse effects* / Q000627:therapeutic use
D007783:Lactones; D013450:Sulfones; C116926:rofecoxib; D009288:Naproxen